These results reveal that the previously shown reduction in tumor progression upon deletion of Acsl4 in hepatocytes is accompanied and most likely mediated by a marked decrease in liver fibrosis in the DEN-CCl4 model of fibrosis-driven HCC. Here, ACSL4 is linked to neoplasm.